Different IV Fluids After Surgery for Chronic Subdural Hematoma
Official title: The Effect of Dextrose 5% in 0.225% Sodium Chloride (D5 1/4NS) on Postoperative Chronic Subdural Hematoma Size and Recurrence Rate
Run by Carilion Clinic · NCT03831997 · Data updated 2026-11-12
Researchers will test whether giving D5 1/4NS after burr hole drainage helps shrink residual space and lowers recurrence in chronic subdural hematoma patients.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 35 (estimated) |
| Sponsor | Carilion Clinic Academic / other |
| Locations | 1 site (Roanoke, Virginia) |
| Status | Recruiting |
| Started | January 17, 2019 |
| Main results expected | January 1, 2030 |
| Study ends | June 1, 2030 |
| Registry record updated | November 6, 2026 |
| Trial ID | NCT03831997 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults diagnosed with chronic subdural hematoma requiring burr hole drainage and able to tolerate the postoperative fluid plan.
✕Probably not a fit
Patients with acute hemorrhage, significant electrolyte issues, or other exclusions may not benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study explores whether postoperative intravenous fluids influence the recurrence of chronic subdural hematoma (CSDH) after burr hole drainage. By administering dextrose 5% in 1/4 normal saline, the study aims to expand brain tissue and reduce the residual cavity, potentially lowering recurrence rates. The trial will compare recurrence risk and remaining hematoma cavity in relation to the fluid strategy and other known risk factors. Outcomes include volume changes on imaging and the need for additional surgery within 3 months or after. The study is conducted at a single center and has no designated control group described.
Why it matters
Potential benefit: If successful, the fluid strategy could reduce CSDH recurrence and the need for subsequent operations.
How similar studies have gone: There is limited prior evidence for this exact fluid strategy in reducing CSDH recurrence; the approach is novel in this context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of chronic subdural hematoma (based on imaging) * Need for surgical intervention (assessed by attending neurosurgeon based on full neurological assessment) * The procedure of choice is burr hole drainage * Cessation of anti-coagulant therapy with accompanying normal lab values in appropriate time frames respective to the drug * Tolerance of supine position Exclusion Criteria: * \<60 years old * Presence of acute hemorrhage, stroke, or parenchymal damage * Neurological deficits not accountable to mass effect * Hyponatremia or inherent electrolyte imbalances * Pregnancy or non-consentable patients * Previous neurological surgery up to 1 year before being considered for the study * Rapid re-expansion of brain observed intraoperatively by attending neurosurgeon * Congestive heart failure or other medical conditions precluding normal postoperative administration of IV fluids * Blood glucose levels \> 135 mg/dL
Where it's running
-
Carilion Roanoke Memorial Hospital
Roanoke, Virginia, United States Recruiting
Study contacts
- Principal investigator: Eric Marvin, DO — Carilion Clinic
- Study coordinator: Eric A Marvin, DO
- Email: eamarvin@carilionclinic.org
- Phone: 5405889711
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Middle Meningeal Artery Embolisation to Prevent Recurrence of Chronic Subdural Hematoma
This study tests whether embolising the middle meningeal artery around the time of hematoma evacuation can reduce recurrence in adults with chronic subdural hematoma.
-
What causes vulnerability in older adults with serious diseases and how it affects care decisions
This study tests how often vulnerability factors appear in older adults with serious illnesses and how these factors influence treatment timing, survival, and quality of life.
-
Coil embolization for unilateral vs bilateral chronic subdural hematomas
This trial tests whether unilateral or bilateral coil-based embolization of the middle meningeal artery helps people with chronic subdural hematoma.
-
Non-Thermal Plasma Used During Surgery to Help Prevent Recurrent Chronic Subdural Hematoma
A randomized trial tests whether applying non-thermal plasma during standard surgery to drain a chronic subdural hematoma can reduce recurrence within 6 months.
-
Enhanced recovery pathway for burr-hole drainage in chronic subdural hematoma patients
This project tests whether an enhanced recovery protocol for adults having burr-hole drainage for chronic subdural hematoma can reduce recurrence and complications compared with past patients.
-
Matched microcatheter and guidewire use for middle meningeal artery embolization in chronic subdural hematoma
This will test whether using a matched Aristotle 14 guidewire and Plato 17 microcatheter during middle meningeal artery embolization works better than surgeons' usual device choices for adults with chronic subdural hematoma.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.